Here are what the editors at HealthDay consider to be the most important developments in Pain Management for March 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Doctors With Malpractice Claims More Likely to Leave Medicine
THURSDAY, March 28, 2019 (HealthDay News) -- Physicians with one or more paid malpractice claims are more likely to leave practice or shift into smaller practice settings, according to a study published in the March 28 issue of the New England Journal of Medicine.
Hearing Loss Before Age 50 Tied to Higher Substance Use
WEDNESDAY, March 27, 2019 (HealthDay News) -- Hearing loss is independently associated with substance use disorders among those aged 49 years and younger, according to a study published in the April issue of the American Journal of Preventive Medicine.
Douglas County, Colorado, Ranked as Healthiest Community
TUESDAY, March 26, 2019 (HealthDay News) -- The 2019 healthiest community in America is Douglas County, Colorado, according to a report published online March 26 by U.S. News & World Report, in conjunction with the Aetna Foundation.
2019 Residency Match Day Was Largest in History
MONDAY, March 25, 2019 (HealthDay News) -- The 2019 Main Residency Match was the largest in history, with a record high of 38,376 applicants for 35,185 positions, according to 2019 Match Day results released by the National Resident Matching Program.
Overall, Physicians Are Happy and Enjoy Their Lives
WEDNESDAY, March 20, 2019 (HealthDay News) -- Overall, physicians are happy and enjoy their lives, according to the 2019 American Academy of Family Physicians (AAFP)/CompHealth Physician Happiness Survey published online March 19.
Analgesics in Pregnancy Do Not Seem to Cause Offspring Asthma
TUESDAY, March 19, 2019 (HealthDay News) -- Analgesics taken during pregnancy, including opioids, antimigraine drugs, and paracetamol, do not appear to cause asthma, according to a study published online March 17 in the European Respiratory Journal.
Average of 8.8 Inactive Ingredients Found in Oral Medications
MONDAY, March 18, 2019 (HealthDay News) -- Oral forms of medications contain an average of 8.8 inactive ingredients, many of which could cause adverse reactions, according to a perspective piece published in the March 13 issue of Science Translational Medicine.
Physician Burnout Rate Increased From 2014 to 2017
FRIDAY, March 15, 2019 (HealthDay News) -- From 2014 to 2017, there was an increase in physician burnout, with early-career physicians being the most susceptible, according to a study published online March 15 in JAMA Network Open.
Opioid Prescriptions Dropped for New Users From 2012 to 2017
FRIDAY, March 15, 2019 (HealthDay News) -- Many providers stopped initiating opioid therapy from July 2012 to December 2017, according to a report published in the March 14 issue of the New England Journal of Medicine.
Knee Pain Not Tied to Activity Levels in Knee Osteoarthritis
THURSDAY, March 14, 2019 (HealthDay News) -- Knee pain is not associated with daily walking levels in individuals with mild-to-moderate, symptomatic knee osteoarthritis (KOA), according to a study published online March 6 in Arthritis Care & Research.
Head of National Cancer Institute Named Acting FDA Commissioner
WEDNESDAY, March 13, 2019 (HealthDay News) -- The U.S. Food and Drug Administration will temporarily be overseen by the head of the National Cancer Institute when FDA Commissioner Scott Gottlieb, M.D., leaves the post next month.
CDC: Most Americans Report Excellent, Good Health
WEDNESDAY, March 13, 2019 (HealthDay News) -- Most Americans report having excellent or good health and have a usual place to go for medical care, according to a report published March 13 for the National Health Interview Survey Early Release Program.
Tramadol May Up Mortality Risk in Osteoarthritis Patients
TUESDAY, March 12, 2019 (HealthDay News) -- The initial prescription of tramadol compared with commonly prescribed nonsteroidal anti-inflammatory drugs may be associated with increased all-cause mortality among patients with osteoarthritis, according to a study published in the March 12 issue of the Journal of the American Medical Association.
Acupressure Reduces Lasting Symptoms in Breast Cancer Survivors
TUESDAY, March 12, 2019 (HealthDay News) -- Acupressure is associated with improvements in co-occurring symptoms in breast cancer survivors with fatigue, according to a study recently published in JNCI Cancer Spectrum.
Four-to-Seven-Day Opioid Rx Likely Sufficient for Acute Pain Treatment
TUESDAY, March 12, 2019 (HealthDay News) -- An opioid supply for seven or fewer days might be sufficient for most patients seen in primary care settings for acute pain who appear to need opioid analgesics, according to research published in the Feb. 15 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Dual Receipt of Opioids Tied to Increased Risk for OD Death
MONDAY, March 11, 2019 (HealthDay News) -- For veterans enrolled in the U.S. Department of Veterans Affairs (VA) and Medicare Part D, receipt of opioids from both VA and Part D is associated with an increased likelihood of death from prescription opioid overdose, according to a study published online March 12 in the Annals of Internal Medicine.
Persistent, Prolonged Opioid Use Occurs After Plastic Surgery
THURSDAY, March 7, 2019 (HealthDay News) -- Persistent and prolonged opioid use occur after plastic and reconstructive surgical procedures, according to a study published online March 7 in JAMA Facial Plastic Surgery.
Menopause Symptoms Linked to Chronic Pain in Midlife
THURSDAY, March 7, 2019 (HealthDay News) -- Menopause symptoms are associated with chronic pain among midlife female veterans, according to a study published online March 4 in Menopause.
FDA Commissioner Dr. Scott Gottlieb Resigns
TUESDAY, March 5, 2019 (HealthDay News) -- In what probably came as a surprise to many, U.S. Food and Drug Administration Commissioner Scott Gottlieb, M.D., announced his resignation on Tuesday. Gottlieb is leaving the FDA because he wants to spend more time with his wife and three young daughters -- twins aged 9 and a 5-year-old -- one official said. He currently commutes each week from the family home in Connecticut to his Washington, D.C., office.
Multidimensional Approach Cuts Unneeded Drug-Drug Interaction Alerts
MONDAY, March 4, 2019 (HealthDay News) -- An iterative, multidimensional quality improvement (QI) effort can reduce interruptive drug-drug interaction (DDI) alerts, according to a study published in the March issue of Pediatrics.
FDA Warns Americans Not to Buy Drugs From Canadian Company
FRIDAY, March 1, 2019 (HealthDay News) -- A large Canadian drug distributor sells unapproved and mislabeled medicines to Americans, the U.S. Food and Drug Administration warned Thursday. The distributor disputes the claim, however.